scispace - formally typeset
P

Philip James Edwards

Researcher at University of London

Publications -  19
Citations -  2554

Philip James Edwards is an academic researcher from University of London. The author has contributed to research in topics: Poison control & Randomized controlled trial. The author has an hindex of 10, co-authored 19 publications receiving 2343 citations.

Papers
More filters
Journal ArticleDOI

Methods to increase response to postal and electronic questionnaires

TL;DR: A randomised controlled trials of methods to increase response to postal or electronic questionnaires found substantial heterogeneity among trial results in half of the strategies, which could improve the quality of health research.
Reference EntryDOI

Methods to increase response rates to postal questionnaires

TL;DR: The trials evaluated 98 different ways of increasing response rates to postal questionnaires and for 62 of these the combined trials included over 1,000 participants, finding substantial heterogeneity among trial results in half of the strategies.
Journal ArticleDOI

The effectiveness of M-health technologies for improving health and health services: a systematic review protocol

TL;DR: This systematic review will summarise the evidence for the effectiveness of mobile technology interventions for improving health and health service outcomes (M-health) around the world and guide future work on intervention development and primary research in this field.
Journal ArticleDOI

Caffeine for the prevention of injuries and errors in shift workers

TL;DR: Caffeine may be an effective intervention for improving performance in shift workers however, there are no trials from which to assess its effect on injuries and there is no reason for healthy individuals who already use caffeine within recommended levels to improve their alertness to stop doing so.
Journal ArticleDOI

More on albumin. Use of human albumin in UK fell substantially when systematic review was published.

TL;DR: Demand for albumin fell steeply after publication of the systematic review and there should be some concern that albumin may have been replaced by non-albumin colloids as there is no compelling evidence that these are superior and these products may also have important adverse effects.